Allosteric regulation of switch-II controls K-Ras oncogenicity
M. H. Yang, T. H. Tran, B. Hunt, R. Agnor, C. W. Johnson, T. J. Waybright, J. A. Nowak, A. G. Stephen, D. K. Simanshu, K. M. Haigis
This study shows that the K104Q mutation reduces oncogenic K-Ras activity in vivo by disrupting GEF-mediated nucleotide exchange and stabilizing switch-II helix through an allosteric network.
bioRxiv · Sep 20, 2022 · PreprintCancer Biology